VIVAX MALARIA
Clinical trials for VIVAX MALARIA explained in plain language.
Never miss a new study
Get alerted when new VIVAX MALARIA trials appear
Sign up with your email to follow new studies for VIVAX MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
3-Day malaria cure could transform treatment
⭐️ CURE ⭐️ Not yet recruitingThis study tests a shorter, higher-dose course of primaquine to cure vivax malaria and prevent it from coming back. Current treatments take too long, so a 3-day course could make it easier for patients to complete therapy. The trial involves over 1,000 people aged 5 and older wit…
Matched conditions: VIVAX MALARIA
Phase: PHASE3 • Sponsor: Menzies School of Health Research • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
Malaria drug combo under scrutiny: could tafenoquine interact?
Disease control Not yet recruitingThis study looks at whether a malaria drug called tafenoquine interacts with two other common malaria treatments (DHA-piperaquine and artesunate-pyronaridine) in adults with vivax malaria. About 507 participants will receive one of the combinations or a delayed treatment to compa…
Matched conditions: VIVAX MALARIA
Phase: PHASE4 • Sponsor: Menzies School of Health Research • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC